Literature DB >> 28063213

Obesity coverage gap: Consumers perceive low coverage for obesity treatments even when workplace wellness programs target BMI.

Elizabeth Ruth Wilson1, Theodore K Kyle2,3, Joseph F Nadglowski3, Fatima Cody Stanford4,5.   

Abstract

OBJECTIVE: Evidence-based obesity treatments, such as bariatric surgery, are not considered essential health benefits under the Affordable Care Act. Employer-sponsored wellness programs with incentives based on biometric outcomes are allowed and often used despite mixed evidence regarding their effectiveness. This study examines consumers' perceptions of their coverage for obesity treatments and exposure to workplace wellness programs.
METHODS: A total of 7,378 participants completed an online survey during 2015-2016. Respondents answered questions regarding their health coverage for seven medical services and exposure to employer wellness programs that target weight or body mass index (BMI). Using χ2 tests, associations between perceptions of exposure to employer wellness programs and coverage for medical services were examined. Differences between survey years were also assessed.
RESULTS: Most respondents reported they did not have health coverage for obesity treatments, but more of the respondents with employer wellness programs reported having coverage. Neither the perception of coverage for obesity treatments nor exposure to wellness programs increased between 2015 and 2016.
CONCLUSIONS: Even when consumers have exposure to employer wellness programs that target BMI, their health insurance often excludes obesity treatments. Given the clinical and cost-effectiveness of such treatments, reducing that coverage gap may mitigate obesity's individual- and population-level effects.
© 2017 The Obesity Society.

Entities:  

Mesh:

Year:  2017        PMID: 28063213      PMCID: PMC6100791          DOI: 10.1002/oby.21746

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  28 in total

1.  Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.

Authors:  Stacy A Brethauer; Ali Aminian; Héctor Romero-Talamás; Esam Batayyah; Jennifer Mackey; Laurence Kennedy; Sangeeta R Kashyap; John P Kirwan; Tomasz Rogula; Matthew Kroh; Bipan Chand; Philip R Schauer
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

2.  A pilot study testing the effect of different levels of financial incentives on weight loss among overweight employees.

Authors:  Eric A Finkelstein; Laura A Linnan; Deborah F Tate; Ben E Birken
Journal:  J Occup Environ Med       Date:  2007-09       Impact factor: 2.162

3.  The Affordable Care Act permits greater financial rewards for weight loss: a good idea in principle, but many practical concerns remain.

Authors:  John Cawley
Journal:  J Policy Anal Manage       Date:  2014

4.  Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations.

Authors:  Christopher N Ochner; Adam G Tsai; Robert F Kushner; Thomas A Wadden
Journal:  Lancet Diabetes Endocrinol       Date:  2015-02-12       Impact factor: 32.069

5.  The impact of obesity on rising medical spending.

Authors:  Kenneth E Thorpe; Curtis S Florence; David H Howard; Peter Joski
Journal:  Health Aff (Millwood)       Date:  2004 Jul-Dec       Impact factor: 6.301

Review 6.  Surgical interventions for obesity and metabolic disease.

Authors:  Lan Vu; Noah J Switzer; Christopher De Gara; Shahzeer Karmali
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-01-09       Impact factor: 4.690

Review 7.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Authors:  J Picot; J Jones; J L Colquitt; E Gospodarevskaya; E Loveman; L Baxter; A J Clegg
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014

Review 8.  What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

Authors:  R Ara; L Blake; L Gray; M Hernández; M Crowther; A Dunkley; F Warren; R Jackson; A Rees; M Stevenson; K Abrams; N Cooper; M Davies; K Khunti; A Sutton
Journal:  Health Technol Assess       Date:  2012       Impact factor: 4.014

9.  Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.

Authors:  John Cawley; Chad Meyerhoefer; Adam Biener; Mette Hammer; Neil Wintfeld
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

10.  Cost-Effectiveness Analysis of Qsymia for Weight Loss.

Authors:  Eric A Finkelstein; Eliza Kruger; Sunil Karnawat
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

View more
  4 in total

Review 1.  Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction.

Authors:  L I Igel; K H Saunders; J J Fins
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

2.  Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015.

Authors:  David R Saxon; Sean J Iwamoto; Christie J Mettenbrink; Emily McCormick; David Arterburn; Matthew F Daley; Caryn E Oshiro; Corinna Koebnick; Michael Horberg; Deborah R Young; Daniel H Bessesen
Journal:  Obesity (Silver Spring)       Date:  2019-10-11       Impact factor: 5.002

Review 3.  Long-Term Weight Loss Strategies for Obesity.

Authors:  Karim Kheniser; David R Saxon; Sangeeta R Kashyap
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

4.  Coverage of obesity and obesity disparities on American Board of Medical Specialties (ABMS) examinations.

Authors:  Siddharth Yarlagadda; Matthew J Townsend; Carl J Palad; Fatima Cody Stanford
Journal:  J Natl Med Assoc       Date:  2021-04-16       Impact factor: 2.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.